What Ceidos SA does

Ceidos SA is a Switzerland-based biotechnology company founded in 2019 that has developed C-Netics, a bioreactor monitoring system purpose-built to deliver continuous, non-destructive, real-time measurements of cell viability and cell density in mammalian cell culture processes. The product is sold as both an R&D tool and a GMP manufacturing instrument, targeting biopharmaceutical manufacturers and life sciences research institutions that currently rely on manual sampling for offline cell-count analysis.

The C-Netics platform is built around a patented microfluidic cartridge equipped with high-end microelectrodes. As cells flow through the cartridge, a dielectrophoretic field induces movement; each cell's individual speed and behavior on the electrodes is monitored to infer viability, while high-resolution microscopy captures morphological detail. Proprietary AI models developed in-house by Ceidos perform automatic cell detection and tracking, producing continuous numerical output without requiring manual sampling or recalibration. The instrument connects to any bioreactor regardless of size or brand via a sterile single-use kit welded onto the bioreactor line, eliminating the contamination and dilution issues associated with traditional offline analyzers.

Ceidos runs an enterprise, demo-led GTM motion: pricing is quote-based, prospective customers are routed through a "Contact us for a demo" workflow, and downloadable technical brochures support evaluation. Revenue is generated from the sale of the C-Netics instrument together with recurring single-use microfluidic cartridge kits consumed per bioreactor run. The company is headquartered in Monthey, Switzerland (Rte de l'Ile-au-Bois 1A) with an administrative mailing address in Sion, and operates with a 1-10 person team. Co-founders Sebastien Walpen (CEO) and Leonard Barras (CTO) lead a roster that includes a life-science engineer, a senior software developer, a senior data scientist, an accounting manager, a board member, and external financial, scientific, and business advisors. Strategic validation partners include Testa Center (Cytiva-affiliated), Kuhner (bioreactor OEM), and HES-SO; the company is also embedded across the Swiss life-sciences support ecosystem (venturelab, bioark, VentureKick, Innosuisse, FIT, aescuvest, EuroStart).

Name

Ceidos SA

Legal name

Ceidos SA

Website

https://ceidos.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

1–10 employees

Short description

Ceidos SA is a Swiss biotechnology company that has developed C-Netics, a real-time bioreactor monitoring system combining microfluidics, dielectrophoresis, high-resolution microscopy, and proprietary AI to deliver continuous cell viability and density data for biopharmaceutical manufacturers and life sciences research institutions.

Ownership category

akta.pro rank

Product category

Bioprocess Monitoring Instruments

NAICS

Analytical Laboratory Instrument Manufacturing (334516), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)

SIC

Laboratory Analytical Instruments (3826), Industrial Instruments For Measurement, Display, And Control (3823)

akta.pro primary industry

Cell-Based & Potency Assays (Bioassays) (HLAGADAH)

Keywords

• Bioreactor monitoring
• Cell viability analysis
• Bioprocess analytics
• Microfluidic cell sensing
• Continuous cell monitoring

Headquarters

HQ city

Sion

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales

Revenue model

1. C-Netics Hardware System: The C-Netics monitoring device is sold as a hardware system. The company generates revenue from the sale of the main instrument along with consumable single-use microfluidic cartridge kits that are replaced for each bioreactor run.
2. Single-Use Consumable Cartridges: Recurring revenue from sterile single-use microfluidic cartridges that are consumed per batch/run, creating repeat purchase opportunities for each bioreactor operation.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Ceidos SA develops and sells C-Netics, a hardware-based bioreactor monitoring system that delivers non-destructive, continuous, real-time measurement of cell viability and cell density. The system combines a patented microfluidic cartridge, dielectrophoresis, high-resolution microscopy, and proprietary AI models into a closed single-use kit that connects to any bioreactor, eliminating manual sampling and contamination risk for mammalian cell cultures in R&D and GMP environments.

Product overview

Ceidos SA offers a single unified product, the C-Netics, which is a hardware-based bioreactor monitoring system. The C-Netics uses a microfluidic cartridge with microelectrodes, high-resolution microscopy, and proprietary AI models to continuously monitor cell viability and density in any bioreactor. The product consists of the C-Netics device, a sterile single-use kit, and microfluidic cartridge components. It is designed for mammalian cells in suspension and is suitable for both R&D and GMP manufacturing settings.

Differentiator

Problem solved

Functional benefit

Brands

• C-Netics: A bioreactor monitoring technology that provides non-destructive, continuous monitoring of cell viability and cell density in real time. The product combines high-resolution microscopy, microfluidics, dielectrophoresis, and AI-powered analysis for bioprocessing applications.

Products and services

• C-Netics Bioreactor Monitoring System A hardware-based bioreactor monitoring device that delivers non-destructive, continuous, real-time measurement of cell viability and cell density for mammalian cells in suspension. It connects to any bioreactor regardless of size or brand via a sterile single-use kit and runs an automated workflow with no manual calibration required, intended for biopharmaceutical manufacturers and life sciences research institutions in R&D and GMP environments.
• C-Netics Sterile Single-Use Microfluidic Cartridge Kit A sterile, closed single-use kit consisting of tubing and a microfluidic cartridge with microelectrodes that is replaced for each bioreactor run, enabling closed-system connection to any bioreactor and serving as the recurring consumable component of the C-Netics system.

Quantifiable outcome

• Eliminates need for manual sampling, reducing contamination risk
• +3 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature4 records

Partnerships

Three partnerships are on record, tiered core and minor.

• Testa CentercoreStrategic or Co-development PartnerCollaboration with Testa Center (associated with Cytiva) for testing and validation of C-Netics technology in an industrial bioprocessing environment. Listed as a downloadable resource for collaboration details.
• KuhnercoreStrategic or Co-development PartnerCollaboration with Kuhner (bioreactor manufacturer) for validation and demonstration of C-Netics integration capabilities with Kuhner bioreactors. Listed as a downloadable collaboration document.
• HES-SOminorStrategic or Co-development PartnerCollaboration with HES-SO (Swiss University of Applied Sciences) for research and development support in life sciences technology.

Recent moves6 records

Expansion highlights5 records

Direct peers

• Hamilton Company: Hamilton is a direct competitor in bioprocess analytics, offering the BEPro and Incyte online biomass/cell viability sensors that target the same bioreactor monitoring workflow as the C-Netics in mammalian cell culture.
• Beckman Coulter Life Sciences: Beckman Coulter's Vi-Cell series is a widely deployed automated cell viability and density analyzer in biopharma QC labs, directly overlapping with the C-Netics use case of routine cell health measurements during bioprocessing.
• Roche CustomBiotech (Cedex): Roche's Cedex Bio and Cedex Bio HT systems are automated analyzers for cell density, viability, and metabolites in bioprocess monitoring — a directly comparable solution to the C-Netics in mammalian cell culture workflows.

Broad incumbents

• Sartorius AG: Sartorius is a global bioprocess solutions incumbent offering bioreactors, PAT tools, and bioanalytics; their broader portfolio competes with Ceidos for in-line bioprocess monitoring budgets across GMP and R&D settings.
• Cytiva (Danaher): Cytiva is a broad bioprocess equipment and consumables incumbent (and an existing Ceidos partner via Testa Center) whose Xcellerex bioreactor and PAT portfolio overlaps with the C-Netics use case at large biopharma customers.
• Agilent Technologies: Agilent is a broad analytical instruments incumbent whose cell analysis and bioprocess analytics portfolio (including Seahorse and acquired bio-analytical assets) overlaps with the broader workflow in which C-Netics competes.
• Yokogawa Electric: Yokogawa's bioprocess and life sciences automation solutions — including in-line cell culture sensors and process analytical technology — compete for the same biopharma monitoring budget that the C-Netics targets.

Emerging players

• Nova Biomedical: Nova Biomedical provides BioProfile and Cell Density analyzers targeting real-time bioprocess analytics in cell culture, representing an emerging in-line and at-line alternative to manual sampling that competes with C-Netics's positioning.
• Aber Instruments: Aber Instruments specializes in dielectric spectroscopy-based online biomass and cell viability monitoring, a closely related but technically distinct approach (radiofrequency vs Ceidos's microfluidic + DEP + microscopy) targeting the same in-line bioreactor monitoring workflow.

Regional players

• Kuhner AG: Kuhner is a Swiss-based bioreactor shaker manufacturer and an existing Ceidos collaboration partner; it competes in adjacent equipment categories and represents both a regional peer and a strategic validation reference for C-Netics integration.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ceidos SA